Category: Policy
Join us and the FDA for a patient focused meeting on amyloidosis
Amyloidosis Research Consortium is hosting a critical meeting with the FDA in Bethesda on November 16th, 2015. This is an unprecedented opportunity: patients can inform the FDA about their experience and unmet needs. At the FDA's request, amyloidosis experts will...
Read More
- Categories
- Archives
- October 2024 (1)
- March 2024 (1)
- February 2024 (1)
- December 2023 (1)
- November 2023 (1)
- October 2023 (1)
- May 2023 (1)
- March 2023 (2)
- February 2023 (1)
- October 2022 (3)
- July 2022 (1)
- June 2022 (1)
- April 2022 (1)
- February 2022 (2)
- November 2021 (2)
- September 2021 (1)
- June 2021 (1)
- May 2021 (1)
- March 2021 (1)
- February 2021 (1)
- January 2021 (2)
- December 2020 (1)
- November 2020 (2)
- October 2020 (1)
- September 2020 (1)
- August 2020 (1)
- July 2020 (1)
- February 2020 (2)
- January 2020 (2)
- December 2019 (1)
- November 2019 (3)
- October 2019 (1)
- September 2019 (3)
- August 2019 (1)
- June 2019 (1)
- May 2019 (2)
- March 2019 (2)
- February 2019 (1)
- January 2019 (1)
- December 2018 (3)
- October 2018 (2)
- September 2018 (1)
- August 2018 (2)
- July 2018 (2)
- April 2018 (3)
- March 2018 (2)
- February 2018 (3)
- January 2018 (2)
- December 2017 (4)
- November 2017 (2)
- October 2017 (1)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- April 2017 (1)
- February 2017 (1)
- December 2016 (2)
- October 2016 (2)
- September 2016 (1)
- July 2016 (3)
- June 2016 (4)
- May 2016 (1)
- April 2016 (2)
- March 2016 (1)
- February 2016 (2)
- December 2015 (1)
- November 2015 (2)
- October 2015 (1)
- September 2015 (1) More
